Inefficacy of platelet transfusion to reverse ticagrelor: To the editor

New England Journal of Medicine

Volumn 372, Issue 2, 2015, Pages 196-197

  Godier, Anne ^a   Taylor, Guillaume ^a   Gaussem, Pascale ^b  

^a FONDATION OPHTALMOLOGIQUE ADOLPHE DE ROTHSCHILD   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; TICAGRELOR; ADENOSINE; ANTIDOTE; PURINERGIC P2Y RECEPTOR ANTAGONIST;

ACUTE CORONARY SYNDROME; AGED; BARE METAL STENT; BLOOD CLOT LYSIS; BRAIN HEMATOMA; BRAIN HEMORRHAGE; BRAIN SCINTISCANNING; CASE REPORT; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CONSCIOUSNESS LEVEL; HEMIPLEGIA; HOSPITAL ADMISSION; HUMAN; HYDROCEPHALUS; LETTER; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; SURGICAL DRAINAGE; THROMBOCYTE TRANSFUSION; TREATMENT FAILURE; ANALOGS AND DERIVATIVES; CHEMICALLY INDUCED; FATALITY; STROKE; THROMBOCYTE COUNT;

ACUTE CORONARY SYNDROME; ADENOSINE; AGED; ANTIDOTES; FATAL OUTCOME; HUMANS; MALE; PLATELET COUNT; PLATELET TRANSFUSION; PURINERGIC P2Y RECEPTOR ANTAGONISTS; STROKE;

EID: 84920585324     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1409373     Document Type: Letter

References (4)

1. Wallentin L, Becker RC, Budaj A, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2009;361:1045-57.
2. Ticagrelor: product information. London: European Medicines Agency (http://www.ema.europa.eu/docs/en-GB/document-library/EPAR-Product-Information/human/001241/WC500100494.pdf).
3. Gurbel PA, Bliden KP, Butler K, et al. Randomized doubleblind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET/OFFSET study. Circulation 2009;120:2577-85.
4. Bonello L, Paganelli F, Arpin-Bornet M, et al. Vasodilatorstimulated phosphoprotein phosphorylation analysis prior to percutaneous coronary intervention for exclusion of postprocedural major adverse cardiovascular events. J Thromb Haemost 2007;5:1630-6.